Benefits, challenges and obstacles of adaptive clinical trial designs

10.1186/1750-1172-6-79

Saved in:
Bibliographic Details
Main Authors: Chow, S.-C, Corey, R
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Review
Published: BMC 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/178164
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-178164
record_format dspace
spelling sg-nus-scholar.10635-1781642024-11-08T22:59:35Z Benefits, challenges and obstacles of adaptive clinical trial designs Chow, S.-C Corey, R DUKE-NUS MEDICAL SCHOOL clinical trial (topic) computer program computer simulation dose calculation drug research food and drug administration methodology phase 1 clinical trial (topic) phase 2 clinical trial (topic) phase 3 clinical trial (topic) review statistical analysis United States article bioassay dose response drug industry human methodology sample size standard treatment outcome Clinical Trials as Topic Data Interpretation, Statistical Dose-Response Relationship, Drug Drug Industry Endpoint Determination Humans Research Design Sample Size Treatment Outcome United States United States Food and Drug Administration 10.1186/1750-1172-6-79 Orphanet Journal of Rare Diseases 6 1 79 2020-10-20T08:10:24Z 2020-10-20T08:10:24Z 2011 Review Chow, S.-C, Corey, R (2011). Benefits, challenges and obstacles of adaptive clinical trial designs. Orphanet Journal of Rare Diseases 6 (1) : 79. ScholarBank@NUS Repository. https://doi.org/10.1186/1750-1172-6-79 1750-1172 https://scholarbank.nus.edu.sg/handle/10635/178164 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ BMC Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic clinical trial (topic)
computer program
computer simulation
dose calculation
drug research
food and drug administration
methodology
phase 1 clinical trial (topic)
phase 2 clinical trial (topic)
phase 3 clinical trial (topic)
review
statistical analysis
United States
article
bioassay
dose response
drug industry
human
methodology
sample size
standard
treatment outcome
Clinical Trials as Topic
Data Interpretation, Statistical
Dose-Response Relationship, Drug
Drug Industry
Endpoint Determination
Humans
Research Design
Sample Size
Treatment Outcome
United States
United States Food and Drug Administration
spellingShingle clinical trial (topic)
computer program
computer simulation
dose calculation
drug research
food and drug administration
methodology
phase 1 clinical trial (topic)
phase 2 clinical trial (topic)
phase 3 clinical trial (topic)
review
statistical analysis
United States
article
bioassay
dose response
drug industry
human
methodology
sample size
standard
treatment outcome
Clinical Trials as Topic
Data Interpretation, Statistical
Dose-Response Relationship, Drug
Drug Industry
Endpoint Determination
Humans
Research Design
Sample Size
Treatment Outcome
United States
United States Food and Drug Administration
Chow, S.-C
Corey, R
Benefits, challenges and obstacles of adaptive clinical trial designs
description 10.1186/1750-1172-6-79
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Chow, S.-C
Corey, R
format Review
author Chow, S.-C
Corey, R
author_sort Chow, S.-C
title Benefits, challenges and obstacles of adaptive clinical trial designs
title_short Benefits, challenges and obstacles of adaptive clinical trial designs
title_full Benefits, challenges and obstacles of adaptive clinical trial designs
title_fullStr Benefits, challenges and obstacles of adaptive clinical trial designs
title_full_unstemmed Benefits, challenges and obstacles of adaptive clinical trial designs
title_sort benefits, challenges and obstacles of adaptive clinical trial designs
publisher BMC
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/178164
_version_ 1821187036925657088